{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:48:39Z","timestamp":1765079319631},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Patients with familial hypercholesterolemia, familial combined hyperlipidemia and hyperlipoprotein(a) are at high cardiovascular risk. Increasing evidence suggest that lifestyle-related risk factors such as physical inactivity, and poor diet quality could influence cardiovascular risk in these patients. Our objective is to review the evidence that supports the role of lifestyle-related factors in the prediction of cardiovascular risk in patients with inherited lipid disorders.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Recent studies have shown that smoking, a poor diet quality, physical inactivity, fitness levels, abdominal obesity, insulin resistance, and type 2 diabetes were associated with the presence of atherosclerosis and long-term cardiovascular outcomes in patients with familial hypercholesterolemia. Recent evidence also suggest that managing other cardiovascular risk factors such as cholesterol levels, obesity, glycemic control, blood pressure, smoking, physical inactivity, and diet quality could reduce long-term cardiovascular risk associated with hyperlipoprotein(a). Whether targeting these risk factors could ultimately decrease cardiovascular risk in these patients remains unknown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Although reducing the number of atherogenic apolipoprotein-B containing particle with lipid-lowering therapy represents the cornerstone of treatment of patients with inherited lipid disorders, lifestyle-related risk factors such as physical inactivity and poor diet quality need to be targeted for the optimal management of these high-risk patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mol.0000000000000387","type":"journal-article","created":{"date-parts":[[2016,12,25]],"date-time":"2016-12-25T16:59:55Z","timestamp":1482685195000},"page":"177-185","source":"Crossref","is-referenced-by-count":16,"title":["Does lifestyle contribute to disease severity in patients with inherited lipid disorders?"],"prefix":"10.1097","volume":"28","author":[{"given":"Benoit J.","family":"Arsenault","sequence":"first","affiliation":[{"name":"Centre de recherche de l\u2019Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec"},{"name":"Department of Medicine, Faculty of Medicine, Universit\u00e9 Laval"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Perrot","sequence":"additional","affiliation":[{"name":"Centre de recherche de l\u2019Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec"},{"name":"Department of Medicine, Faculty of Medicine, Universit\u00e9 Laval"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Couture","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, Universit\u00e9 Laval"},{"name":"Institute of Nutrition and Functional Foods, Universit\u00e9 Laval"},{"name":"Lipid Research Center, CHU de Qu\u00e9bec-Universit\u00e9 Laval, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230917","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.115.018791","article-title":"Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)","volume":"133","author":"de Ferranti","year":"2016","journal-title":"Circulation"},{"key":"R2-20230917","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrendo.2016.69","article-title":"Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism","volume":"12","author":"Ellis","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"R3-20230917","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"R4-20230917","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"R5-20230917","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N Engl J Med"},{"key":"R6-20230917","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCGENETICS.113.000400","article-title":"Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective mendelian randomization study and replication in a case\u2013control cohort","volume":"7","author":"Arsenault","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"R7-20230917","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"R8-20230917","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jama.2015.1206","article-title":"Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus","volume":"313","author":"Besseling","year":"2015","journal-title":"JAMA"},{"key":"R9-20230917","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1161\/ATVBAHA.116.307514","article-title":"Coronary heart disease, peripheral arterial disease, and stroke in familial hypercholesterolaemia: insights from the SAFEHEART registry (Spanish Familial Hypercholesterolaemia Cohort Study)","volume":"36","author":"Perez de Isla","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R10-20230917","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2796.2004.01405.x","article-title":"The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients","volume":"256","author":"Jansen","year":"2004","journal-title":"J Intern Med"},{"key":"R11-20230917","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/hrt.2003.022764","article-title":"Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia","volume":"90","author":"Neil","year":"2004","journal-title":"Heart"},{"key":"R12-20230917","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/1471-2458-6-262","article-title":"Relative risk for cardiovascular atherosclerotic events after smoking cessation: 6\u20139 years excess risk in individuals with familial hypercholesterolemia","volume":"6","author":"Kramer","year":"2006","journal-title":"BMC Public Health"},{"key":"R13-20230917","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.ATV.18.2.309","article-title":"Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada","volume":"18","author":"Pimstone","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R14-20230917","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.CIR.97.9.871","article-title":"Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene","volume":"97","author":"Gaudet","year":"1998","journal-title":"Circulation"},{"key":"R15-20230917","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","article-title":"General and abdominal adiposity and risk of death in Europe","volume":"359","author":"Pischon","year":"2008","journal-title":"N Engl J Med"},{"key":"R16-20230917","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0140-6736(05)67663-5","article-title":"Obesity and the risk of myocardial infarction in 27\u200a000 participants from 52 countries: a case\u2013control study","volume":"366","author":"Yusuf","year":"2005","journal-title":"Lancet"},{"key":"R17-20230917","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3109\/07853890.2011.605387","article-title":"Mapping body fat distribution: a key step towards the identification of the vulnerable patient?","volume":"44","author":"Arsenault","year":"2012","journal-title":"Ann Med"},{"key":"R18-20230917","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.ijo.0800445","article-title":"Importance of intra-abdominal visceral fat accumulation to coronary atherosclerosis in heterozygous familial hypercholesterolaemia","volume":"21","author":"Nakamura","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"R19-20230917","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.atherosclerosis.2016.09.010","article-title":"Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia","volume":"254","author":"Mangili","year":"2016","journal-title":"Atherosclerosis"},{"key":"R20-20230917","first-page":"1","article-title":"Physical inactivity: the biggest public health problem of the 21st century","volume":"43","author":"Blair","year":"2009","journal-title":"Br J Sports Med"},{"key":"R21-20230917","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.atherosclerosis.2003.12.027","article-title":"Exercise capacity and heart rate recovery as predictors of coronary heart disease events, in patients with heterozygous familial hypercholesterolemia","volume":"173","author":"Pitsavos","year":"2004","journal-title":"Atherosclerosis"},{"key":"R22-20230917","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"R23-20230917","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2014.06.1190","article-title":"Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: a population-based prospective cohort study","volume":"64","author":"Akesson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R24-20230917","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jacc.2010.11.041","article-title":"Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence","volume":"57","author":"Folsom","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R25-20230917","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/2047487315602015","article-title":"Ideal cardiovascular health and risk of cardiovascular events in the EPIC-Norfolk prospective population study","volume":"23","author":"Lachman","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"R27-20230917","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1056\/NEJMoa1605086","article-title":"Genetic risk, adherence to a healthy lifestyle, and coronary disease","volume":"375","author":"Khera","year":"2016","journal-title":"N Engl J Med"},{"key":"R28-20230917","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2016.04.054","article-title":"Statins in familial hypercholesterolemia: consequences for coronary artery disease and all-cause mortality","volume":"68","author":"Besseling","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R29-20230917","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(14)61399-4","article-title":"PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"key":"R30-20230917","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1194\/jlr.R053066","article-title":"Current therapies for lowering lipoprotein(a)","volume":"57","author":"van Capelleveen","year":"2016","journal-title":"J Lipid Res"},{"key":"R31-20230917","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/1359105309345170","article-title":"Perceived risk and representations of cardiovascular disease and preventive behaviour in people diagnosed with familial hypercholesterolemia: a cross-sectional questionnaire study","volume":"15","author":"Claassen","year":"2010","journal-title":"J Health Psychol"},{"key":"R32-20230917","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jama.2011.1202","article-title":"Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: a randomized controlled trial","volume":"306","author":"Jenkins","year":"2011","journal-title":"JAMA"},{"key":"R33-20230917","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3945\/jn.114.191775","article-title":"Serum lipid responses to weight loss differ between overweight adults with familial hypercholesterolemia and those with familial combined hyperlipidemia","volume":"144","author":"Mateo-Gallego","year":"2014","journal-title":"J Nutr"},{"key":"R34-20230917","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1756-0500-5-181","article-title":"No significant improvement of cardiovascular disease risk indicators by a lifestyle intervention in people with familial hypercholesterolemia compared to usual care: results of a randomised controlled trial","volume":"5","author":"Broekhuizen","year":"2012","journal-title":"BMC Res Notes"},{"key":"R35-20230917","first-page":"CD001918","article-title":"Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia","author":"Malhotra","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R36-20230917","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"R37-20230917","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N Engl J Med"},{"key":"R38-20230917","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients: the glagov randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00041433-201704000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T08:22:04Z","timestamp":1694938924000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041433-201704000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0000000000000387","relation":{},"ISSN":["0957-9672","1473-6535"],"issn-type":[{"value":"0957-9672","type":"print"},{"value":"1473-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}